How many autoimmunity tests per year will have to be performed on the array machine to break even?
Given the present volume of tests, would there be an annual net contribution and, if so, how much?
If half of the patients have Medicare coverage (DRG reimbursement includes all tests), would the laboratory break even on the equipment? If not, should the equipment be acquired anyway?
